Subjects in intervention and control groups at baseline
| Intervention group(81 houses) | Control group(83 houses) | |
|---|---|---|
| Data expressed as n (%) unless otherwise indicated. | ||
| Numbers do not always add up to totals because of missing data. | ||
| No. of subjects at baseline | 115 (44M, 71F) | 117 (49M, 68F) |
| Mean (SD) age (years) | 26.4 (16.2) | 27.1 (16.0) |
| Current smokers | 28 (25) | 40 (34) |
| Positive skin test to mould | 38/101 (38) | 41/94 (44) |
| Preventer medication in last 4 weeks | 90 (78) | 89 (76) |
| Reliever medication in last 4 weeks | 81 (70) | 78 (67) |
| Wheeze in last 4 weeks | 85 (74) | 95 (81) |
| Wheeze disturbs sleep: | ||
| Never | 47 (41) | 35 (30) |
| Less than weekly | 18 (16) | 31 (26) |
| At least weekly | 49 (43) | 51 (44) |
| Wheeze limits speech | 23 (20) | 17 (15) |
| Wheeze affects activity: | ||
| Not at all | 43 (37) | 48 (41) |
| A little | 40 (35) | 46 (39) |
| Moderately | 25 (22) | 14 (12) |
| A lot | 7 (6) | 9 (8) |
| Rhinitis | 74 (64) | 71 (61) |
| Rhinoconjunctivitis | 44 (38) | 40 (34) |
| Rhinitis affects activity: | ||
| Not at all | 61 (54) | 62 (53) |
| A little | 32 (28) | 39 (34) |
| Moderately | 15 (13) | 10 (9) |
| A lot | 6 (5) | 5 (4) |
| No. with any follow-up data | 95 (83) | 87 (74) |